微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -2.53% | -97.66% | 93.11% | 136/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | -36.7% | -89.47% | -1178.75% | 139/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | -2.87% | 29.66% | -55.98% | 118/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | -1.84% | 32.1% | -43.75% | 118/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | -1.28% | 7.91% | 93.39% | 125/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | -19.37% | -205.52% | -374.75% | 132/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | -4.08% | -574.42% | -50.55% | 126/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | -2.71% | -697.06% | -94.96% | 125/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | -1.39% | -1490% | 78.08% | 123/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -6.34% | -188.18% | -837.21% | 120/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 0.86% | 82.98% | 352.94% | 108/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -0.34% | 10.53% | -440% | 117/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 0.1% | -84.13% | 104.55% | 114/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -2.2% | 80.36% | -568.09% | 112/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 0.47% | -68.87% | 223.68% | 112/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | -0.38% | -156.72% | -160.32% | 117/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 0.63% | 57.5% | 105.63% | 102/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | -11.2% | -109.11% | -841.72% | 129/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 1.51% | -27.05% | 125.37% | 107/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 0.67% | -47.24% | 67.5% | 112/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 0.4% | -62.96% | 107.47% | 104/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | -5.36% | -630.3% | -358.74% | 115/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 2.07% | -42.98% | 62.99% | 92/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 1.27% | -19.11% | 17.59% | 95/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 1.08% | -14.29% | 6.93% | 67/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 1.01% | -49.8% | -72.18% | 113/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 3.63% | 24.74% | 131.21% | 79/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 1.57% | 134.33% | 24.6% | 91/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 1.26% | 44.83% | -37.38% | 77/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 2.01% | -2.09% | -30.86% | 107/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 2.91% | 15.94% | 334.33% | 82/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 0.67% | -68.54% | -22.99% | 96/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 0.87% | 2.35% | -57.66% | 82/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 2.06% | 185.42% | -18.13% | 106/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 2.51% | -28.69% | 17.84% | 80/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 2.13% | 40.13% | 150.59% | 80/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 0.85% | 26.87% | 18.06% | 63/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 0.72% | -78.95% | -79.55% | 100/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 3.52% | 20.14% | 131.58% | 65/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 1.52% | -10.59% | 126.87% | 74/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 0.67% | 9.84% | -80.41% | 63/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |